Here is why Novo Nordisk A/S (NVO) is among the Best Longevity and Anti-Aging Stocks to Buy

On June 17, Berenberg expert Kerry Holford raised the firm's terms people connected Novo Nordisk A/S (NYSE:NVO) to DKK 325 from DKK 300 and maintained a Buy standing connected the shares.

Earlier, connected June 11, Novo Nordisk A/S (NYSE:NVO) announced that the United Kingdom's Medicines and Healthcare products Regulatory Agency approved the Wegovy pill arsenic an adjunct to a reduced-calorie fare and accrued carnal activity. The support makes the therapy the archetypal oral GLP-1 receptor agonist authorized for value absorption successful adults surviving with obesity oregon overweight who besides person astatine slightest 1 weight-related aesculapian condition. The determination was supported by information from the Phase 3 OASIS 4 objective proceedings and expands Novo Nordisk's obesity attraction portfolio by offering patients a non-injectable alternate to existing therapies.

Founded successful 1923 and headquartered successful Bagsværd, Denmark, Novo Nordisk A/S (NYSE:NVO) is simply a planetary healthcare institution specializing successful chronic conditions similar diabetes and obesity. It is chiefly known for processing lifesaving GLP-1 therapies similar Ozempic and Wegovy, but it besides targets the underlying metabolic and cardiovascular diseases that trim lifespan.

While we admit the imaginable of NVO arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Most Overvalued Quantum Computing Stocks According to Short Sellers and 7 Best Pet Care Stocks to Buy for Consistent Recurring Revenue.

Disclosure: None.  Follow Insider Monkey connected Google News.